Drugs Made In America Acquisition II Corp. (also referred to in listings as a SPAC/blank-check vehicle) is structured as an acquisition-focused corporation rather than an operating company. Incorporated in 2024, the company’s core purpose is to identify, negotiate, and complete a business combination—such as a merger, share exchange, asset acquisition, ...Drugs Made In America Acquisition II Corp. (also referred to in listings as a SPAC/blank-check vehicle) is structured as an acquisition-focused corporation rather than an operating company. Incorporated in 2024, the company’s core purpose is to identify, negotiate, and complete a business combination—such as a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar transaction—between the SPAC and one or more target businesses. Based on the available description, the company’s search is centered on companies associated with the pharmaceutical industry.
From a business perspective, SPACs like DMIIR are typically “pre-deal” entities: until a qualifying target is identified and approved by stakeholders, the company generally does not produce product revenue in the way an operating pharmaceutical manufacturer would. Instead, it concentrates on deal sourcing, evaluation, and due diligence, as well as meeting regulatory and listing requirements. This makes leadership execution and sponsor relationships particularly important—because the quality of the eventual target (and the terms of the combination) largely determines investor outcomes.
Product/service-wise, the company does not offer conventional products; its “service” to investors is access to a future acquisition strategy. In practice, costs are associated with the SPAC lifecycle (transaction and advisory fees, legal/compliance expenses, listing and ongoing public-company costs, and other professional costs). The provided financial snapshots indicate limited operational metrics (for example, no meaningful margins/operating profit in the snapshot period), which is consistent with a blank-check status prior to a completed deal.
Financially, the SPAC’s market capitalization and enterprise value depend on its trading price and capital structure rather than ongoing operations. The provided data shows a relatively small share/volume figure and a market cap in the low single-digit millions USD range, consistent with early-stage or low-float trading for a newly formed acquisition vehicle. Metrics such as return on assets/equity are present but are not indicative of operating performance because the company’s principal activities occur around identifying and closing a transaction.
Key people include CEO Roger Bendelac, who serves as the company’s chief executive following a leadership transition noted in the provided materials. With only a small number of full-time employees reported (2), the company reflects a typical SPAC operating model: a minimal internal workforce supported by external professionals and deal advisors.
Overall, DMIIR’s “wish” as expressed by its mandate is to successfully complete a pharmaceutical-focused business combination within the timeframe and conditions required by its governing documents and applicable exchange rules—turning the pooled capital into an operating enterprise and creating value for shareholders after the initial SPAC period.
YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength.
QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes.
RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three).
$0
—
—
Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day.
$4.2M
+2859.7%
+1.4%
Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials.
—
—
—
Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on).
—
—
—
Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales.
—
—
—
Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock.
$-1.0M
-424.1%
-68.5%
FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine.
—
—
—
Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe.
0.0%
+100.0%
-0.9%
Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking.
0.09x
-63.0%
-36.0%
Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground.
